Getting Ozempic through the SUS depends on lists, protocols, and government decisions. Here is how the process works and what to expect at each step.
If you searched for Ozempic SUS, you've probably found mixed information. Some pages say the drug is available, others say it isn't, and a neighbor swears her doctor sorted everything out in a week. The truth is that semaglutide access through the public system runs on lists, protocols, and government decisions, not just on a prescription. This article picks up where the basics leave off, so you can understand the process before you walk into a health unit.
Public access is not the same as a private prescription
In private care, a prescription from your doctor usually settles the matter. The SUS works differently. Coverage follows national lists, clinical protocols, and formal decisions made by the federal government. The RENAME, the National List of Essential Medicines, sets out which medicines the system can offer. Being on that list is only the first step.
Many patients get stuck on the difference between the drug exists in the SUS and the drug is covered for your specific condition. Those are two separate questions. A medicine can be available for one indication and not another, so the useful question is whether semaglutide is covered for your diagnosis and under which rules.
Some high-cost medicines fall under the Componente Especializado da Assistência Farmacêutica, known as CEAF. This component is organized around specific conditions and treatment lines, and each one follows its own protocol. Incorporating a new technology usually depends on a recommendation from Conitec, followed by a ministerial decision. That sequence explains why changes can feel slow.
Who decides what gets covered
Conitec, the National Committee for Health Technology Incorporation, evaluates the evidence on a technology and issues a recommendation on whether the SUS should incorporate it. That recommendation is not the final word. The Ministry of Health makes the decision, and the outcome is published in the Diário Oficial da União.
Clinical Protocols and Therapeutic Guidelines, or PCDTs, add another layer. Each one spells out the diagnostic criteria, prescribing criteria, and follow-up for a specific condition. If your case doesn't meet the protocol's rules, the drug can stay out of reach even when it has been officially incorporated for another use.
Policy changes over time, so check the current status before you rely on any article, this one included. Conitec publishes its recommendations on its own pages, and the Diário Oficial records formal decisions. OzemNews keeps an eye on these policy updates, which can help you spot changes early. Confirm the details with official sources before you act, though.
The indication changes almost everything
Type 2 diabetes and obesity follow different pathways. They use different documentation and different criteria, so a rule that applies to one may not apply to the other. What worked for a friend with diabetes may not carry over to an obesity case.
The process usually starts in primary care. Your basic health unit team evaluates you, orders the first tests, and refers you to an endocrinologist or another specialist when the protocol requires it. The specialist confirms the diagnosis and checks whether you meet the criteria.
What usually goes into the file
The file typically includes a medical report, relevant lab results, and a record of treatments already tried. Some protocols require earlier treatments before a newer drug is allowed. Find out in the PCDT for your condition whether that applies to you, because requirements differ and can change over time. Your team can show you the exact criteria the protocol uses.
From prescription to pharmacy counter
Your prescription must follow the rules of the program, and those rules set how long it stays valid. Ask your health unit for the current window rather than trusting an old figure you read online. Validity can differ by program and by medication.
Pickup usually happens at one of a few places: the basic health unit, a specialized pharmacy, or a designated dispensing point. Which one applies depends on your city and state, so your team can tell you where patients in your region collect the medicine.
The SUS may supply a specific presentation or brand that differs from what a private pharmacy sells. Check the label before you leave the counter. Compare the pen type, the dose, and the schedule against your prescription. If anything looks different, ask the pharmacist before you start the first injection.
Keep one folder with copies of the prescription, the dispensing receipt, and your dose schedule. This habit saves time at renewals and answers the question of what you actually received.
Keeping treatment going without gaps
Renewal usually depends on follow-up visits and lab tests. The protocol sets the interval, so get the exact timing in writing. Book the next appointment before the current prescription runs out, because waiting until the final week is how gaps happen.
Supply interruptions do happen. If your medication is unavailable, don't stop it or change the dose on your own. Call your care team and ask what alternatives the protocol allows and whether a temporary option exists.
Under some protocols, a dose change may require a new prescription, which can restart the paperwork. Raise the change at a visit where you can also address other issues, and bring your current dose schedule and recent lab results so the team can act in one go.
Report side effects and treatment problems, even the ones that seem minor. Recording them in your file means they can be handled and documented. That record also matters for future renewals, because the team reviews it when deciding how to proceed.
When access is denied or delayed
If the SUS denies or delays your access, request the decision in writing, along with the legal or technical basis for it. A written answer gives you something concrete to work with, whether you appeal or go to court.
The administrative appeal comes first. The deadline is stated in the decision letter, so read it carefully, because missing it can close that route. The SUS ombudsman, the Ouvidoria, takes complaints and can push a case forward. Many people file through the federal Fala.BR platform, but check the current steps on the official site before you file.
The Defensoria Pública provides legal assistance to people who cannot afford a lawyer. For federal matters, the Defensoria Pública da União handles cases, while state Defensorias handle state-level issues. If the administrative route stalls, a defender can help you decide whether to go to court.
Court decisions take time. Depending on the case, an order may name a specific product, and it does not guarantee fast delivery. Plan around that reality rather than assuming a ruling will solve the problem quickly.
Many patients who face a denial look for others who have been through the same thing. If you want to see how people handled their own denials and appeals, OzemNews is a useful place to follow what others have gone through. While you wait, some people consider buying the medicine privately. Prices for medicines in Brazil are regulated by CMED, the Chamber of Regulation of the Medicines Market, which sets maximum prices. Talk to your doctor before spending money, and confirm that a private purchase fits your health plan and your treatment.
A quick checklist and closing thoughts
Bring these four items to every appointment:
- Your ID document
- Your SUS card
- The current prescription
- Your most recent lab results
The process can be frustrating, and that reaction is normal. Good records, careful timing, and clear communication with your team can help you move through each step. Keep your folder updated, confirm information with official sources, and ask questions whenever something doesn't add up. Staying organized and watching for policy changes, including the coverage news on OzemNews, can help you keep pace as the rules evolve.
FAQ
Is Ozempic available through the SUS?
It depends on the indication. Semaglutide may be covered for one condition and not another, so check the current Conitec decision and the PCDT that applies to your diagnosis.
How long is an SUS prescription valid?
The validity period depends on the program and the rules in force. Confirm it with your health unit instead of relying on an older figure from someone else's experience.
What should I do if my Ozempic request is denied?
Ask for the denial in writing, note the appeal deadline in the letter, and contact the Ouvidoria. If the administrative route doesn't resolve the case, a Defensoria Pública can advise you on going to court.
Can I stop treatment if the pharmacy runs out?
No. Don't stop or change your dose on your own. Contact your care team and ask which alternatives the protocol allows while the supply is restored.
Sources
- Conitec: Comissão Nacional de Incorporação de Tecnologias no SUS
- Ministério da Saúde (CEAF, PCDTs e políticas do SUS)
- Diário Oficial da União (Imprensa Nacional)
- Anvisa: Câmara de Regulação do Mercado de Medicamentos (CMED)
- Fala.BR: Plataforma Integrada de Ouvidoria e Acesso à Informação
- Defensoria Pública da União (DPU)
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app